Review




Structured Review

Rexin Pharmaceuticals rexin-g
Rexin G, supplied by Rexin Pharmaceuticals, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/rexin-g/rexin+g/pmc12271757-240-10-0
Average 90 stars, based on 1 article reviews
rexin-g - by Bioz Stars, 2026-09
90/100 stars

Images

Related Articles

other:

Article Title: Macro-, micro- and nanoscale drug delivery systems in oncotherapy: current clinical status.
Article Snippet: Rexin-G consists of nanoparticles that have a high-affinity collagen-binding motif, derived from the von Willebrand factor (vWF), on the surface [228].

Article Title: Macro-, micro- and nanoscale drug delivery systems in oncotherapy: current clinical status.
Article Snippet: Gendicine and Rexin-G are gene therapies based on viral vectors.

Article Title: Macro-, micro- and nanoscale drug delivery systems in oncotherapy: current clinical status.
Article Snippet: The mechanism of action of Rexin-G appears to be in line with the ATR principle.

Article Title: Viral and non-viral vectors in gene therapy: current state and clinical perspectives
Article Snippet: Rexin-G was the world's first gene therapy drug based on RV; it was used as a monotherapy to treat advanced chemotherapy-resistant cancer and was approved by the Philippine Food and Drug Administration (BFAD) for all solid tumours in 2006.

Article Title: Gene and Cell Therapy for Sarcomas: A Review
Article Snippet: No vector-neutralizing antibodies nor non-target DNA integration was detected in phase 1/2 studies using Rexin-G [ , ].

Article Title: Macro-, micro- and nanoscale drug delivery systems in oncotherapy: current clinical status.
Article Snippet: Unlike in active targeting where the target is the tumor cell, Rexin-G targets the tumor ECM.

Article Title: Macro-, micro- and nanoscale drug delivery systems in oncotherapy: current clinical status.
Article Snippet: Sarcoma patients had higher PFS and OS at higher Rexin-G doses than at a lower Rexin-G dose [126].

Article Title: Aptamer-based applications in delivering cancer gene therapies and beyond: state of the art and the missing links to clinical translation.
Article Snippet: • Gene therapies have shown inefficient tumor targeting and side effects.. • Traditional gene therapies were successfully conjugated to nucleic acid



Similar Products

90
Rexin Pharmaceuticals rexin-g
Rexin G, supplied by Rexin Pharmaceuticals, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/rexin-g/rexin+g/pmc12271757-240-10-0
Average 90 stars, based on 1 article reviews
rexin-g - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier

90
Rexin Pharmaceuticals cyclin g1 rexin-g
Cyclin G1 Rexin G, supplied by Rexin Pharmaceuticals, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/rexin-g/cyclin+g1+rexin+g/pmc12268860-303-2-7
Average 90 stars, based on 1 article reviews
cyclin g1 rexin-g - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier

Image Search Results